iAPOGEE Visiting Scholarship Program, 2021–2026
International Alliance for PharmacoGenetic Epidemiology Excellence” (iAPOGEE) Visiting Scholarship program hosts researchers in (pharmaco-/genetic-) epidemiology, biostatistics and/or bioinformatics at the Pharmacoepidemiology and Drug Safety Research Group at the Faculty of Mathematics and Natural Sciences, University of Oslo.
Photo: University of Oslo.
The research visit will enable applicants to gain experience with perinatal pharmacoepidemiology and large Norwegian registries and/or birth cohorts. The researcher will be included in ongoing research projects together with PharmaSafe researchers selected according to the applicant’s preferences and expertise. The project will be multidisciplinary and conducted in close collaboration with international and national partners. Expected outcomes include a publication in a high-ranking journal.
The research program is funded by The Research Council of Norway.
Visiting scholars should hold a master degree, PhD or equivalent within (pharmaco-/genetic-)epidemiology, biostatistics or bioinformatics.
Applications are evaluated according to their track-record, personal qualifications, and the fit between the applicants’ background, research record, and their proposed plans for their stay. Visiting scholars are expected to be in residence during their term, the duration of which can be short or longer (max 6 months). Partners within the iAPOGEE Visiting Scholarship program will be prioritized when other qualifications are similar between applicants.
Each scholar is expected to give a presentation and a webinar or online course during their research stay.
Candidate visiting scholars should submit the following
- CV, including publication list
- A personal statement including (max 2 pages):
- motivation and the expected outcome of the research visit
- description of prior experience within epidemiology, biostatistics and/or bioinformatics (incl. experience with different statistical methods and software)
- proposed start and end date
- a budget plan o names and contact information for two professional references
- One recommendation letter
We offer financial support for housing, living expenses and travel for the researcher (see below). Visiting scholars will have access to work space, computer, library, meetings and workshops organized by the PharmaSafe research group. The University of Oslo can provide assistance with finding housing and other formalities connected to relocation for the purpose of this scholarship. Read more about being a visiting researcher at UiO
- Single/with spouse/partner without children: up to NOK 18 000 per month
- Family: up to NOK 33 000 per month (depending on number of children)
All costs must be documented. Only actual costs related to housing will be covered. Travel expenses will be covered in addition. Other extraordinary expenses can be covered as agreed upon (e.g. visa expenses).
It is also possible to apply for funding to cover round-trip travel costs (cheapest mode of travel). Applicants may seek funding to cover travel costs for a spouse/partner and children under the age of 18, provided that the fellowship grant has been awarded for at least three months. The family members must reside together with the fellowship-holder/researcher throughout the entire fellowship period.
Application deadline: April 1st 2022 / June 1st 2022 etc.
The candidate will be hosted by the PharmacoEpidemiology and Drug Safety Research Group headed by Professor Nordeng at the Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo.
For information about potential research projects, please contact Professor Hedvig Nordeng, E-mail: firstname.lastname@example.org
For practical information, please contact research coordinator Leiry Cornejo Chavez, email@example.com
For information about being an international researcher at the University of Oslo, read more here: www.uio.no/english/about/jobs/ismo/
Restrictions given by Norwegian health authorities and by the University of Oslo due to the COVID-19 pandemic will at all times apply.